Login / Signup

How can we better manage drug-resistant OAB/DO? ICI-RS 2018.

Christopher J ChermanskyBrigitte SchurchMohammad Sajjad RahnamaiMarcio Augusto AverbeckSachin MaldeVito ManciniFrancoise ValentiniArun Sahai
Published in: Neurourology and urodynamics (2020)
Further research is required to optimize these procedures and to better understand which patients will benefit from the various options available in managing refractory OAB.
Keyphrases
  • drug resistant
  • end stage renal disease
  • multidrug resistant
  • acinetobacter baumannii
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors